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On  the  basis  of biochemical,  genetic,  and  biological  data,  the  chicken  major 
histocompatibility  complex  (MHC) 1 has  been  divided  into  three  subregions:  B-L, 
B-F,  and  B-G.  Unlike  the  B-F  and  B-L  regions,  which  code  for  homologues  of 
mammalian  class  I  and  class  II  MHC  antigens,  there  is  no  known  mammalian 
homologue of B-G antigens.  B-G antigens  are erythroid  differentiation  antigens  as 
they are restricted in their expression to erythrocytes (RBC) and erythroid progenitors 
(1). This raises the question whether the B-G locus should be considered as part of the 
MHC or whether it should be considered as just another blood group locus fortuitously 
linked to the chicken MHC. However, B-G genes resemble classic MHC genes in the 
sense that  (a)  the gene products are highly polymorphic and the degree of polymor- 
phism is at least comparable to that exhibited by class I antigens of the chicken and 
the mouse (2), (b) they exist in strong linkage disequilibrium with class I  (B-F) genes 
in  outbred  populations  (3),  and  (c)  they  share  several of the  same immunological 
characteristics  as  classic  MHC  antigens  as  they  are  more  immunogenic  and  less 
tolerogenic than other non-MHC antigens (4-6). Because B-G antigens are expressed 
only on erythrocytes and their progenitors, it is no surprise that they are not involved 
as targets for skin  graft rejection or graft-vs.-host (GVH)  reactions  (7-9).  However, 
these antigens might be expected to serve as effective barriers or targets for rejection 
of erythroid  chimerism.  These  experiments  were  partially  designed  to  answer  this 
question. 
A  second interesting property of B-G antigens is that all animal species that have 
been studied,  including alligators, chickens, mice, rats, and humans, have high titers 
of natural antibodies against B-G polymorphic determinants (10,  11). The specificity 
of this  high  background  response  has  been  studied  by  fusing  lipopolysaccharide- 
stimulated spleen cells from unimmunized mice with myeloma cells and screening the 
hybrids  for the  production  of antibody against  chicken  RBC  (CRBC)  (12).  Clones 
specific  for  CRBC  represented  >1%  of the  total  hybridomas  and  >95%  of them 
secreted antibody against polymorphic CRBC determinants. Based on these and other 
observations,  a  model  for the  advantages of genetic  polymorphism as  a  protection 
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against  antigen  mimicry  by  parasites  has  been  proposed  (12,  13).  One  of  the 
predictions of the model is that the presence of natural antibody against polymorphic 
determinants of other individuals of the same or different species results from priming 
by  cross-reactive bacterial  antigens  (14-17).  Such  natural  antibodies  may  prevent 
bacterial infections  (12)  or serve as a  protection against  the development of cancer 
(18,  19). Because polymorphic determinants on B-G antigens may be important cross- 
reactive determinants, against which a significant proportion of the B cells in a mouse 
spleen might be directed, an understanding of their chemical nature, immunogenicity, 
and tolerogenicity might give important clues regarding the functional significance of 
polymorphism of cell surface antigens. 
Recent  evidence  strongly  suggests  that  B-G  antigens  are  highly  immunogenic 
targets for humoral immunity  (10)  and also for the production of antigen-specific T 
cell helper factor  in  the  mouse  (20).  Thus,  it  is probably important  to  maintain  a 
profound  state  of tolerance  to  such  potentially immunogenic  determinants,  which 
may be cross-reactive with environmental antigens, as even a low level immune attack 
on  them  may lead to disastrous autoimmune  reactions. In this paper, we show that 
there  is a  critical period in  embryogenesis during which  the  induction  of allogenic 
erythrocytic chimerism leads to the development of severe autoimmune  anemia and 
lymphomas in adult life, and evidence is presented that the immune response to B-G 
determinants is responsible for the pathological events that follow. 
Materials  and  Methods 
Animals.  Fertilized eggs  of SC  and  FP  strain  chickens  were  purchased  from  Hy-Line 
International, Johnston, IO. These eggs are hybrids between different inbred strains of white 
Leghorn chickens. The SC and FP birds carry the B2/B  2 and BIS/B  21 MHC alleles, respectively. 
All chickens were hatched and raised in the facilities of the University of Alberta Edmonton, 
Alberta, Canada. Fertile eggs from randomly bred white Leghorn chickens were obtained from 
the University of Alberta poultry research farm.  Fertile eggs from BI4/B  I4, BIS/B  I5, BlO/B la, 
BI~/B  13, and B21/B  2a strains were also used for GVH assays. These strains are maintained in the 
poultry breeding facilities of the University of Alberta. 
Production of Chimeras.  Two different methods for generating hematopoietic chimeras using 
the SC and FP strains were used in the study. 
For parabiosis, two  12-d-old embryos of the two different known  genotypes (SC and  FP) 
were joined together through their chorioallantoic membranes (CAM) and sealed with paraffin 
wax.  At  day  12  of incubation, windows were marked on  the  midpoint of the  long axis  (as 
described later for splenomegaly) over a  forked vein. The eggshell and the shell membranes 
were then removed so that  the CAM were fully uncovered. Immediately thereafter, the two 
genetically different eggs were joined together by their exposed CAM using paraffin wax, and 
then returned to the incubator. Care was taken to turn the parabionts at least once daily. Close 
to the time of hatching, the parabionts were put in nylon stockings and separated from each 
other with masking tape, in such a way that each chick hatched in different compartments of 
the nylon stocking. 
Hematopoietic  chimeras  were  also  generated  by  stem  cell  transfer.  The  source  of the 
hematopoietic stem cells was the embryonic spleen. Routinely, 30 pooled spleens of 15-, 17-, or 
21-d-old SC  or FP  embryos were  used  as  the  donor cell population.  Spleens were  minced 
carefully in  10 ml RPMI  1640 serum-free medium until single cell suspensions were obtained. 
The cells were then allowed to settle for 20 min through  10 ml of medium in  12-ml test tubes. 
The supernates, which contained the hematopoietic stem cells (21),  were harvested. The cell 
concentration was adjusted so that  1.2 ×  107 non-RBC spleen cells were injected intravenously 
into 15-d-old SC or FP embryos. The same number of 17- or 2 t-d-old spleen cells were, in some 
experiments, also administered either intravenously to 17-d-old SC embryos or intraperitoneally 
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Production ofAnti-B Sera.  Specific  alloantisera were  produced by reciprocal immunizations 
between strains SC and FP. Each bird received three injections each of 2 ml of citrated adult 
whole blood every 2nd d. 6 d after the last injection, the hemagglutination  titer was determined. 
If the titer was lower than 1:32, the above immunization procedure was repeated after a 2-wk 
rest  period. As the strains used are not inbred for all non-B loci, the immune sera produced 
were extensively absorbed with erythrocytes from many different members of the host strain. 
Absorption was carried out at room temperature for 30 rain using equal volumes of antiserum 
and packed RBC. The procedure was repeated three times. Finally, the serum was aliquoted in 
small volumes and stored at -30°C. 
Detection of Chimerism.  All birds generated by the two methods described previously were 
tested for RBC chimerism using the haplotype-specific anti-B locus sera, produced as described 
above. Two methods were used for determining the extent of chimerism. 
The RBC agglutination method was the assay routinely used for a  qualitative and semi- 
quantitative estimate of chimerism. Before  typing the putative chimeras, the strength of the 
antiserum was characterized by typing different mixtures of RBC from the two strains used. 
Generally, a  10% chimerism was easily detected, and a strong antiserum could often detect as 
little as 5% chimerism. 
The cellular radioimmunoassay was  also used; details on this assay  have been published 
elsewhere (22). Briefly,  107 RBC cells from the putative chimeras were incubated with 0.1 ml 
of specific  alloantiserum for  30 min at  room temperature. Then the cells  were  washed  four 
times and further incubated with 0.2 ml of 125I-rabbit anti-chicken immunoglobulin  (Ig). After 
incubation for 30 min at room temperature, the washing procedure was repeated and the cells 
were harvested and counted. The degree of chimerism was estimated by comparing the counts 
found with those from artificial mixtures. 
GVH Reactions.  Cell-mediated responsiveness was analyzed by two manifestations of GVH 
reactivity, namely, the splenomegaly and the CAM-pock reactions. 
For the splenomegaly reaction, the procedure was as has been described previously (23). The 
reaction involves spleen enlargement as measured by increment in weight that results from the 
intravenous injection of immunocompetent lymphocytes into 12-d-old embryos measured 4 d 
postinjection. The assay is known to measure alloreactivity resulting from major B complex 
differences. 
Cell-mediated responsiveness was also measured by the CAM-pock reaction. This involves 
the formation of pocks (lesions of characteristic morphology and size) after inoculation  of donor 
immunocompetent lymphocytes onto the CAM of 12-d-old embryos differing from the donor 
lymphocytes at the B locus. Pocks are enumerated 4 d postinoculation (24). 
Donor Cell Preparation.  Preparation of peripheral blood lymphocytes (PBL)  was as follows: 
Heparinized (10 U/ml) peripheral blood was obtained from appropriate donors. The blood 
was then distributed in 5-ml culture plastic tubes (4 ml/tube) and centrifuged at 600 rpm for 
6  min.  The  lymphocyte-rich plasma  supernatant  was  collected  while  avoiding any  RBC 
contamination. The lymphocytes were washed twice in RPMI 1640 by centrifugation at  1,200 
rpm for 6 min. Finally, the cells were resuspended, and viable counts were made using trypan 
blue dye. 
For spleen cell preparation, donor spleens were removed under sterile conditions and minced 
in RPMI  1640 until a single cell suspension was obtained. Cell clumps were allowed to settle 
out for  15 min under gravity in 15-ml culture plastic tubes (~10 ml/tube) and the single-cell- 
containing supernatant was collected. The cells were washed twice and counted as before. 
Results 
Hematopoietic chimeras were produced by administering  embryonic spleen cells to 
allogeneic chick embryos at  different stages  of embryogenesis. The  immunological 
and pathological characteristics of these chimeras differed dramatically depending on 
the stage of embryonic development at which they were generated. 
Long-term  GVH Tolerance of Chimeras Generated at Days  12 and  15 of Embryonic Develop- 
ment.  Chimerism induced by parabiosis of day 12 embryos was stable and was found 
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published  data  (25).  All seven birds tested  for erythroid  chimerism  at  120 wk of age 
were found to be between  10 and 50% chimeric for donor-type erythrocytes. Successful 
chimerism  was similarly induced  at day  15 ofembryogenesis  by intravenous  injection 
of embryonic  spleen cells. All  13 birds of this group  have been shown previously to be 
chimeric  for  FP  type  erythrocytes  (22).  The  degree  of success  in  generating  day  15 
chimeras  in three different groups was  100%, 85%, and  80%  (data not shown). A  bird 
judged  to be chimeric had at least 5% of donor type erythrocytes, and only these birds 
were included  in the analysis. 
Two  types  of GVH  assays  were  used  to  assess  T  cell-mediated  immunity  against 
MHC  alloantigens: the GVH  splenomegaly  reaction and the CAM-pock  reaction. All 
experimental  birds used in these studies were erythroid chimeras  at the time of GVH 
testing. 
Table  I  shows  the  results  obtained  when  lymphocytes  from  eight  FP  birds  were 
tested individually  for their ability to cause GVH  splenomegaly  reactions.  In experi- 
ment  1, lymphocytes  from three 20-wk-old chimeric FP birds (FP*), generated  at day 
TABLE  I 
GVH Reactivity* of Adult Chimeric Birds, Generated  at Days 12 and 15 of 
Embryogenesis, as Assayed by Splenomegaly 
Source of donor cells 
Weight of spleens 4 d postinjection 
SC hosts:~  Outbred hosts 
mg 
Experiment 1§ 
FP*  1  12.0 ±  0.4 (a)  78.5 ±  14.6 
FP* 2  12.4 ±  0.6 (a)  58.5 ±  13.4 
FP* 3  11.3 ±  0.4 (a)  81.2 ±  16.7 
FP normal control  I  70.8 ±  8.2 (b)  127.8 ±  25.9 
Experiment 2¶ 
FP*  l  10.5 +  0.4 (a)  65.8 +  21.5 
FP* 2  10.5 +_ 0.5 (a)  85.0 ±  50.0 
FP* 3  11.6 +  0.5 (a)  65.6 ±  32.2 
FP* 4  9.3 ±  0.6 (a)  52.2 ±  13.4 
FP* 5  9.1 ±  0.5 (a)  69.0 ±  24.2 
FP normal control  H  74.0 ±  62. (b)  134.0 +  25.0 
SC normal controll]  11.2 +  0.6 (a)  147.0 ±  37.5 
* Whole blood was washed twice in RPMI 1640 serum-free medium. 0.1 ml of 
1:3  reconstituted whole blood was  used  in  both experiments to assay  for 
GVH splenomegaly, as described in Materials and Methods. 
:~ 9-12 host embryos were used per experimental group. Results are shown as 
mean ±  SE. Groups (a) and (b) of experiments 1 and 2 differ significantly 
(P <  0.00I). 
§ Three FP*  birds, 20 wk of age, made chimeric with SC after parabiosis at 
day  12 ofembryogenesis. 
H  FP and SC control birds used in these experiments were age-matched birds 
that  had  been  injected  at  the  15th  d  of  embryogenesis  with  syngeneic 
embryonic stem cells. 
¶ Five FP* birds, 7 wk old, made chimeric with SC after stem cell infusion at 
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12 of embryogenesis by parabiosis, were tested for their ability to cause splenomegaly 
when  injected  into  embryos  of  the  donor-type  strain  or  into  third-party  outbred 
embryos.  In experiment  2,  lymphocytes  from  five FP birds  made chimeric  (FP*)  at 
day  15 of embryogenesis, were also examined for their ability to cause splenomegaly. 
As can be seen, complete tolerance was induced in both types of experimental birds. 
The reaction caused by the injection of lymphocytes from FP* birds into SC embryos 
was  identical  with  that  obtained  when  SC  embryos  were  injected  with  adult  SC 
lymphocytes. The specificity of the reaction was shown by the ability of lymphocytes 
from chimeric birds to cause GVH  splenomegaly when injected into outbred 12-d-old 
embryos. When lymphocytes from normal and tolerant birds were compared for their 
ability to  cause  GVH  reactivity after  injection into outbred  embryos,  it  was  found 
that the tolerant lymphocytes showed a  lower reactivity. This is most likely a  result of 
the induction of cross tolerance. 
Table  II  shows  the  results  obtained  when  lymphocytes  from  eight  chimeric  SC 
(SC*)  birds were  tested  individually for  their ability to  induce GVH  pocks.  In this 
table, chimeras generated at day 12 parabiosis and day  15 after stem cell injection are 
included in two different experiments. The CAM-pock assay used in these experiments 
enumerates  alloreactive  lymphocytes  that  are  placed  onto  the  CAM  of allogeneic 
TABLE II 
GVH Reactivity* of Adult Chimeric Birds, Generated at Days 12 and t5 of 
Embryogenesis, as Assayed by the CAM-pock Assay 
Source of donor cells 
Number of pocks 4 d postinoculation 
FP hosts:~  Outbred hosts 
mean :t: SE 
Experiment 1§ 
SC* 1  0  (7) (a)  12.0 zt: 6.6 
SC* 2  0  (8) (a)  12.6 :t: 4.2 
SO* 3  0  (8) (a)  10.2 + 3.4 
SC normal control  22.7  zi: 6.4 (b)  31.5 :l: 9.4 
Experiment][ 
SC* 1  0  (8) (a)  55.0 + 9.6 
SC* 2  0  (7) (a)  22.5 :t: 8.7 
SC* 3  0  (8) (a)  24.8 :t: 11.4 
SC* 4  0  (7) (a)  24.0 + 8.6 
SC* 5  0  (8) (a)  18.7:1:6.5 
SC normal control  43.5  :t:  5.5 (b)  56.1 +  15.0 
* Whole blood was washed twice in RPMI 1640 serum-free medium. 0.1 ml of 
h3 (experiment  1) or h2 (experiment  2) reconstituted whole blood was used 
in both experiments to assay for GVH CAM-pock reactivity as described in 
Materials and Methods. 
:~ 9-12 host  embryos  were injected per experimental group.  The number of 
CAM recovered is given in parenthesis.  Groups (a) and (b) of experiment 1 
and 2 differ significantly (P <  0.001). 
§ Three SC birds,  16 wk old, made chimeric with FP after parabiosis at day 12 
of embryogenesis. 
]] Five SC birds, 20 wk old, made chimeric with FP after stem cell infusion at 
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embryos. Pocks of characteristic morphology and size are formed on the CAM of the 
embryos within 4 d  when the donor immunocompetent lymphocytes differ from the 
embryos at  the  MHC  region.  The  CAM-pock  assay  is,  therefore,  a  very sensitive 
technique in assessing the degree and specificity of tolerance. As can be seen in Table 
II, complete and specific tolerance was induced  in both types of chimeras as assayed 
by this GVH reaction. 
A total of 91  SC* and 29 FP* birds were generated at day 12 or day 15 and tested 
individually  in  different  experiments  over a  period  of 4  yr.  Complete  and  specific 
tolerance was found to be a permanent property of most of these birds that remained 
chimeric over a  long period of time. 
Specific Absence of Altoantibodies, Natural or Induced, in Chimeras Generated at Days 12 and 
15 of Embryogenesis.  Two approaches were used to analyze the state of responsiveness, 
at  the humoral level, toward donor RBC-associated MHC alloantigens of chimeras 
made at days  12 and  15 of embryonic development. The first was the measurement 
of the specificity of preexisting, natural  anti-RBC  throcyte alloantibody  (10,  11)  in 
the  serum  of otherwise  untreated  chimeras.  The  second  was  the  measurement  of 
alloantibody in  the serum of chimeras that  had been immunized with donor blood 
under conditions  that  are known  to elicit  a  good  alloantibody  response  in  normal 
birds. 
Sera from normal adult  birds contain natural antibodies against B-G alloantigens 
of  the  species,  other  than  those  expressed  as  self  antigens  (10,  11,  and  B.  M. 
Longenecker, unpublished  data). A  more sensitive, indirect  agglutination  technique 
is required to reveal these antibodies, as direct hemagglutination is never found using 
these sera. The results shown in Table III demonstrate that all 10 SC* chimeras tested 
had  natural  antibodies  against  third-party  BIa/B  19 RBC,  but  only 2 of 10  demon- 
strated natural antibodies against donor-strain RBC. These two positive sera probably 
represent  the  early  appearance  of induced  anti-donor-strain  alloantibodies,  which 
occurs in a  minority of day 15 chimeras and which will be described below. 
The  second  approach  was  to  intentionally  immunize  a  group  of SC*  chimeras, 
generated at  day  15,  with  donor-type FP adult  RBC  mixed with  RBC  from third- 
party B14/B a4 donors.  The sera obtained at day  12 after immunization, using estab- 
lished protocols for making alloantibodies (26), contained alloantibodies reacting with 
B14/B ~4 RBC, but  no donor strain anti-FP alloantibodies were detected  (Table IV). 
Thus, these chimeras maintained a  high level of humoral tolerance to both B-G and 
B-F MHC antigens expressed on donor-strain RBC. 
Immunological  Properties of Chimeras  Generated at  Day  17 of Emb~yogenesis.  Table V 
shows the immunological properties of nine SC* chimeric birds tested at 7 wk of age. 
TABLE  III 
Natural Antibodies in the Sera* of SC* Chimeras Generated at Day 15 of 
Embryogenesis 
Indirect agglutination of RBC from 
SC(BZ/B z)  FP(BlS/B21)  B19/B~9 
o/~Oll  2/1o  ~o/ao 
* From 6-wk-old chimeras. 
:~ As described in Longenecker et al. (10). 
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TABLE  IV 
Alloantibodies in SC Normal and Chimeric Birds after RBC Immunization * 
with FP and/or B14/B 14 RBC 
Group  Immunization with 
Direct agglutination~ on 
RBC from 
FP  Bla/B14 
SC normal  FP RBC  5/5  NT§ 
SC*  FP and B14/B  TM  0/12  12/12 
SC*  BI4/B  TM RBC  0/4  4/4 
* 12-wk-old birds were injected intravenously three times on alternate days 
with RBC from a  total of 8  ml of blood from age-matched donors.  RBC 
agglutination was tested 10-12 d after the first injection. 
:~Agglutination  titers  ranged  from  1:8-1:64  in  positive  sera  and  <1:2  in 
negative sera. 
§ Not tested. 
TABLE  V 
Immunological Properties of Chimeras Generated at Day 17 of Emb~yogenesis 
Source of donor  Chimer- 
lymphocytes and sera  ism§ 
CAM-pocks enumerated 4 d after 
lymphocyte inoculation on 
Direct 
agglutination:~ titers 
measured on RBC of 
FP  SC 
FP hosts[[  SC hosts[[  Outbred hosts[[  (B~5/B2,) (B2/B:,) 
%  mean  ±  SE 
SC normal control  0  51.3 ±  6.9  0 (5)  18.2 zl: 7.8  0  0 
SC* 1  10-20  0 (8)  0 (5)  12.3 +  4.6  0  0 
SC* 2  10-20  0 (7)  0 (5)  9.5 •  3.5  0  0 
SC* 3  20  0 (8)  0 (6)  22.4 +  4.9  1/2  0 
SC* 4  10-20  0 (8)  NT~  16.6 +  4.6  a/l~  0 
SC* 5  10-20  0 (6)  NT  27.4 zl: 15.6  0  0 
SC* 6  30  NT  NT  NT  0  0 
SC* 7  10  NT  NT  NT  1/16  0 
SC* 8  20  NT  NT  NT  1/~  0 
SC* 9  30  NT  NT  NT  1/16  0 
* Lymphocytes from 7-wk-old SC birds, made chimeric at day 17 of embryogenesis, were tested for ability 
to cause GVH and CAM-pock reactions upon inoculation onto appropriate host embryos, as indicated. 
The sera from the same birds were tested for their ability to agglutinate RBC of the donor- or host-type 
strain. 
~: Direct RBC agglutination titers were never found in numerous control birds. 
§ Chimerism in  this group of experimental birds was estimated by RBC  agglutination as described in 
Materials and Methods. 
[I 9-12 host embryos were used per experimental group. The number in parentheses represents the number 
of recovered membranes. 
¶ Not tested. 
Successful  erythrocytic chimerism  was  induced  in  all  members  of this  group  and 
ranged  from  ~10  to  30%.  Lymphocytes  from  five  randomly  chosen  birds  showed 
complete  and  specific GVH  tolerance  when  tested  with  donor  type  embryos.  (In 
another  experiment  [data  not  shown], six  randomly  chosen birds  showed the same 
results.)  However,  in  contrast with  the chimeras generated at  day  12  or  day  15  of 
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alloantibodies  detectable  at  7 wk of age.  By 8-10  wk,  all chimeras  tested were  found 
to  have  alloantibodies  that  reacted  specifically  with  donor-type  RBC  (Table  VI). 
Birds  that  made  anti-donor  RBC  alloantibodies  nevertheless  remained  specifically 
tolerant  to  donor-embryo  GVH  alloantigens.  To  test  whether  these  alloantibodies 
might  also react with donor-type  lymphocyte  (B-F)  alloantigens,  the sera were tested 
for their capacity  to  inhibit GVH  reactivity of donor-type  lymphocytes.  This  inhibi- 
tion  of GVH  splenomegaly  is  a  very  sensitive  assay  for  anti-B-F  (8)  as  well  as  for 
alloantibodies  against  other  T  lymphocyte  alloantigens  (27).  None  of the sera  from 
the day  17 chimeras  was able to inhibit GVH  splenomegaly,  although  these sera had 
hemagglutinating  alloantibodies  against donor-type  RBC  (Table VII), 
Development  of Autoimmunity and Lymphomas in Day  17 Chimeras.  83% of the chimeric 
TABLE  VI 
Specificity of Serum A lloantibodies from Nonimmunized SC * Chimeras 
Generated  at Day 17 of Embryogenesis 
Direct agglutination* on RBC from 
SC (B2/B  2)  B19/B  19  B13/B  13  B14/B  TM  BlS/B  16  FP (B~5/B 21) 
0/6  0/6  0/6  0/6  6/6~:  6/6 
* Sera from six  different chimeric birds, 8-10  wk  old,  were  tested with the 
RBC of different genotypes. 
:~ Number positive per number tested; direct agglutination titers ranged from 
1/4-1/16. 
TABLE  VII 
Absence of GVH Inhibition Activity in the Sera of Chimeric Birds That Have Antibodies against RBC of 
the Donor-type Strain 
Source of 10  e do- 
nor lymphocytes  Type of serum 
Agglutination titer of 
serum tested on RBC of 
Weight of spleens 4 d after 
injection (mean ±  SE)* 
FP  SC (B2/B ~)  FP (B'S/B  ~')  SC (B'3/B  'a)  (B1S/B  21) 
SC normal  SC normal  0  0  115.0 +  13.6 
SC normal  SC anti-FP~:  %6  0  119.0 ±  24.0 
SC normal  SC*  1§  1/16  0  126.0 ±  13.5 
SC normal  SC* 2§  1/4  0  127.0 +  15.7 
SC normal  SC* 3§  t/32  0  112.1 +  17.9 
SC normal  SC* 4§  i/4  0  105.7 ±  16.3 
SC normal  SC* 5  1/16  0  120.2 ±  6.7 
mg 
FP normal  SC normal  74.3 ±  9.5 
FP normal  SC anti-FP  l 7.5 ±  2. I 
FP normal  SC*  l  69.0 +  5.2 
FP normal  SC * 2  83.5 -I- 6.1 
FP normal  SC* 3  77.5 +  6.7 
* 10  n purified  PBL were incubated for  1 h  at  room  temperature in  1 ml of 50% serum obtained from 
various donors as indicated. After washing once, these cells were injected into appropriate hosts and their 
GVH reactivity measured 4 d later by weighing the excised spleens of the hosts. 
:~ The SC antiLFP serum tested was obtained after immunization of SC birds with FP whole blood and 
subsequently absorbing the serum with SC cells. 
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birds  generated  at  day  17  and  a  minority  (~15%)  of day  15  chimeras  eventually 
developed severe, antibody-mediated  hemolytic anemia. An early sign of the disease, 
which occurred after  16 wk of age, was the loss of color of their normally red combs. 
The  RBC  from  these  birds  were  found  to  be  strongly  Coombs's positive  after  the 
addition  of rabbit-anti-chicken  Ig.  Sera  from  these  birds  also contained  antibodies 
that  react  with  lymphocytes from both host-  and  donor-type antigens,  also demon- 
strating an autoimmune state  (Table VIII). When heavily diseased  birds were bled, 
their  RBC  showed  signs  of spontaneous  agglutination  and  the  presence  of large 
numbers  of erythroblasts.  Chimerism  was  undetectable  at  this  time  and  they wet'e 
severely  immunosuppressed  as judged  by the  lack of general  GVH  reactivity  (data 
not  shown).  100%  of the  diseased  birds  died  by  10  mo of age.  On  autopsy, splenic 
atrophy and extensively metastasizing lymphomas were found in the majority of these 
birds.  Large  bursal  tumors  were  always  found,  suggesting  a  B  cell  origin  of the 
lymphomas. 
Chimeras  Generated  at  Hatching  (Day  21  of Embryonic  Development).  Chimeras  were 
produced  at  day  21  by intraperitoneal  injection  of spleen  cells  from either  day  15 
embryos or day 21 hatched chicks. In both groups, successful chimerism ranging from 
10  to  30%  was achieved  in  the  majority  of birds  (85%)  when  tested  at  3  wk of age 
(Table  IX). These birds, although chimeric for donor RBC, displayed normal GVH 
reactivity against donor alloantigens when tested at 3 wk of age (Table IX). The same 
birds,  when  tested  at  16 wk of age,  had  lost  detectable  chimerism  and  maintained 
GVH  reativity  against  donor alloantigens.  Only  1 out of 22 birds  tested  developed 
detectable anti-donor-strain RBC alloantibodies,  and all birds remained healthy until 
they were killed. 
Discussion 
Table  X  summarizes  the  immunological  and  pathological  characteristics  of the 
RBC  chimeras  generated  at  different  stages  of embryonic  development.  Although 
chimeras  generated  at  different  times  displayed  similar  degrees  of RBC chimerism, 
which  ranged  from  5  to  40%,  they  showed  vastly  different  immunological  and 
pathological  characteristics.  All  chimeras  generated  at  day  12  and  most  chimeras 
TABLE VIII 
Demonstration by Cellular Radioimmunoassay of Anti-Lymphocyte Autoantibodies in 
the Sera of Sick SC* Birds Whose Chimerism Was Generated  at Day 17 of 
Emb(yogenesis 
Source of 
serum 
Lymphocytes* of 
SC (B2/B ~)  FP (B1S/B~)  B21/B21  B~a/B la 
SC control  367  ±  17 
SC* l  2,587 ±  366 
SC* 2  2,548  --- 260 
SC* 3  3,158  -  348 
cpm + SD~ 
1,073 + 49  436  -  26  715 +  122 
9,075 -+ 160  5,802  +  1,392 3,508 -  376 
6,448 + 576  4,306 ±  488  3,736  ± 282 
7,768 ±  1,056  4,075  ±  847  4,095  ± 519 
* 107 PBL from birds of different genotypes were incubated for 45 min with 0.1 ml of 
a 1:10 dilution of test sera, the cells were washed, and then incubated with 0.1 ml 
of lznI-labeled rabbit anti-chicken Ig. After rewashing, the cells were harvested and 
counted in a gamma counter. 
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TABLE  IX 
Immunological  Characteristics of Chimeras  Generated at Day 21 of Emb(yogenesis 
Properties examined at 
Source of 
donor lym- 
phocytes 
•  3 wk of age  16 wk of age 
Direct agglu- 
RBC* chi-  CAM-pocks:~  tinationDirect  agglu-titers  RBC chi-  CAM-pocks§  tination titers 
formed on FP  formed on FP  merism  measured on  merism  measured on  hosts  hosts  FP RBC  FP RBC 
%  mean + SE  %  mean ± SE 
SC normal  0  54  ±  11.3  0  0  53.2 4-  12.1  0 
SC*  1[I  30  NT¶  0  0  43.1  ±  9.6  0 
SC* 2  30  NT  0  0  53.2 :t: 7.6  0 
SC* 3  ND**  36.3+ 8.0  0  0  45.4 +  8.4  0 
SC* 4  20  43.l+ 5,3  0  0  42.2 ±  14.6  0 
SC* 5  I0  44.6± 8.6  0  0  45.7 _  3.4  0 
SC* 6  30  56.2+ 7,5  0  0  NT  0 
SC* 7  20  NT  0  0  48.3 +  8.6  0 
* Chimerism was estimated by both  RBC agglutination and by the radioimmunoassay as described in 
Materials and Method. 
:~ The ability of 106 PBL to cause GVH  reactions was measured by counting pocks on the CAM of FP 
embryos 4 d  after inoculation. 
§ The ability of 1:3  washed and reconstituted  whole blood  to cause GVH  reactions was measured by 
countined pocks on the CAM of FP embryos 4 d  after inoculation. 
II sc  chimeras were generated at hatching by intraperitoneal injection of spleen cells either from 15-d-old 
FP embryos or from 2 l-d-old newly hatched chicks. 
¶ Not tested. 
** Not detectable. 
TABLE  X 
Immunological  and Pathological  Characteristics of Avian-hematopoetic 
Chimeras  Generated at Different Stages of Embryonic Development 
Proportion of birds with 
Chimeras  Number 
RBC chi-  of birds  Specific  Specific  Hemolytic 
made at  merism  anemia, 
day  tested  anti-donor  anti-donor 
GVH  antibody  lympho- 
mas 
% 
12"  10-40  8  0/8  O/8  0/8 
15~  5-40  36  0/36  8/36  6/36 
17§  10-30  22  0/22  13/22  t8/22 
211I  10-30 at  22  22/22  1/22  0/22 
3 wk 
0  at 
>16 wk 
* By parabiosis. 
:~ By intravenous injection of 15-d-old allogeneic embryonic stem cells. 
§ By intravenous injection  of  17-d-old allogeneic embryonic allogeneic stem 
cells. 
11 By intraperitoneal injection of 15-d-old allogeneic embryonic stem cells. C.  HAVELE, T.  G. WEGMANN, AND B. M.  LONGENECKER  331 
generated at day  15 were classic hematopoietic chimeras  (25)  in the sense that  they 
maintained profound long-term chimerism and specific tolerance for all donor MHC 
alloantigens (B-F, B-L, and B-G) at both the humoral and cell-mediated level. The 
apparent absence of natural anti-donor strain antibody measured by indirect hemag- 
glutination in these chimeras was of particular interest. Normal adult chickens as well 
as humans, mice, rats, and alligators have been shown to possess natural antibodies 
against  polymorphic  determinants  on  B-G  region-encoded  antigens  expressed  on 
CRBC  (10-13).  Normal  adult  chickens  contain  natural  antibodies  against  B-G 
antigens  of the species with  the exception of their own  B-G antigens.  Most of the 
healthy  adult  chimeras  were  also  found  to  lack  natural  antibodies  against  donor- 
strain  B-G antigens.  In this respect, the immunological properties of these chimeras 
with respect to donor antigens were identical to those of normal birds with respect to 
their own B-G antigens. If natural antibodies against B-G as well as RBC blood group 
antigens on CRBC  are protective and arise  because of infection with cross-reactive 
bacteria (10-13, 28), it might be predicted that chickens made chimeric and tolerant 
of many  different  B-G specificities might  be  more  susceptible  to  certain  types  of 
bacterial infections. 
Chimeras produced at a  later stage of embryonic development, that  is at day  17, 
displayed  specific  tolerance  for  GVH  reactivity,  but  a  high  proportion  of them 
developed alloantibodies against donor-strain RBC. At the same time, no antibodies 
against  donor  strain  lymphocytes were  detected using  a  sensitive GVH-inhibition 
assay.  This  assay  is  known  to  be especially sensitive  for the  detection of anti-B-F 
alloantibodies  (8).  B-G  and  B-F  antigens  are  both  well  expressed  on  RBC  (13). 
Nevertheless,  our  data  strongly  suggest  that  tolerance  to  B-F  is  maintained  even 
though B-G tolerance has spontaneously broken. The appearance of specific anti-B-G 
alloantibodies was the earliest detectable sign preceding the development of autoim- 
munity. These antibodies were apparently ineffective at eliminating chimerism. This 
was followed by the development of  severe Coombs's-positive anemia, the development 
of anti-lymphocyte autoantibodies, severe immunosuppression, and the development 
of extensively metastasizing lymphomas. It seems likely that autoimmunity developed 
because the early anti-B-G alloantibodies plus the continuous presence of donor-type 
RBC  in high proportion led to the production of anti-host antibodies, possibly as a 
result of the presence of donor B-G antigens that cross-react with host B-G specificities 
(29).  This process could lead to the development of severe antibody-mediated hemo- 
lytic anemia. Examples are reported in the literature in which autoimmunity can be 
induced  by  chronically  immunizing  with  antigens  that  cross-react  with  self.  For 
example, autoimmunity is known to be induced in mice after prolonged immunization 
with xenogeneic RBC (30) or with malaria-infected syngeneic RBC  (31). 
The autoimmune birds described in this paper developed massive lymphoid tumors. 
The  association  between  generalized  autoimmunity  and  lymphoid  neoplasms  also 
exists in individual patients (32) and in NZB mice. NZB mice develop autoantibodies 
against  thymus ceils when  they are  1 mo old  (33)  and  subsequently develop anti- 
RBC,  anti-DNA,  anti-RNA,  and  anti-G  antibodies  (Gross-type  murine  leukemia 
virus-related antigen). 25% of these mice develop lymphoid neoplasia (34). It appears 
that  the  experimental  system  described  in  chickens  resembles,  in  many  ways,  the 
naturally occurring autoimmune disease in NZB mice. 
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reduced  during embryogenesis. The lymphomas observed in  the current  work were 
similar to those of avian leucosis, which is a neoplasm of the B cell system induced by 
an RNA tumor virus in chickens (35). It is possible that chronic stimulation of the B 
cell system led to the activation of the virus and the induction  of lymphomas. The 
development of B cell lymphomas during chronic GVH disease has been described in 
mice  (36)  where  it  was  suggested  that  abnormal  induction  of donor  T  cells  on 
autoreactive F~ B cells can initiate the production of autoantibodies and that chronic 
antigenic stimulation eventually leads to uncontrolled proliferation and the develop- 
ment  of lymphomas (37).  It  is not  clear whether  the pathological  process observed 
here involves a  classic GVH reaction, but  the development of bursal  tumors might 
suggest that the B cell system received the chronic antigenic stimulation which led to 
the development of malignancy. 
Attempts to  induce  GVH  tolerance at  hatching  failed,  although  successful  RBC 
chimerism  was  temporarily  produced.  Similar  results  were  obtained  when  donor 
spleen  cells  for chimerism  induction  were obtained  from day  15  embryos or newly 
hatched chicks. This shows that  RBC progenitors exist in the newly hatched spleen 
despite the apparent  presence of a  lymphoid microenvironment and the absence of 
detectable erythroid microenvironment (21). It is of interest that full GVH competence 
for donor-type MHC  antigens was maintained  in  the  presence of a  high  degree of 
RBC  chimerism.  This strongly suggests  that  the  relevant  MHC  antigens  for GVH 
stimulation in the chicken are not those expressed on erythrocytes (B-G or B-F), but 
like in mammalian systems, class II molecules (B-L antigens)  are the strongest GVH 
stimulators. 
An  interesting  picture  that  emerges  for our  studies  is  the  existence  of a  period 
during embryonic development, sometime between days 15 and 21, when the embryo 
is particularly susceptible to the induction of autoimmunity and lymphomas after the 
infusion  of allogeneic stem cells. The chick thymus becomes lymphoid at day  12 of 
embryogenesis (38).  All of the chimeras produced by parabiosis at this time and the 
majority of the chimeras produced by stem celt infusion at day 15 remained healthy, 
specifically unresponsive, and chimeric for their entire life span. By these criteria, the 
immunological status of these birds with  respect  to donor antigens  is equivalent  to 
that of a normal animal with respect to its own antigens. 
The finding that there are critical stages of embryonic development during which 
either tolerance or immunity can be induced  is not new. Buxton  (39)  reported that 
the administration of killed Salmonella pullorum to chicken embryos leads to tolerance 
if the antigen is administered before the  16th d of embryogenesis. Administration of 
the  antigen  at  later  times  of embryogenesis  did  not  induce  tolerance.  The  same 
conclusion was reached by Mitchison (40) using turkey RBC. Both authors accounted 
for the  importance of the  time at  which  antigen  is  administered  as a  result  of the 
transfer of maternal antibodies  from the yolk sac to the embryonic circulation  that 
occurs on  the  15th  d  of incubation.  It  is  possible that  the  aforementioned  natural 
alloantibodies to B-G antigens  also appear in  the embryo at  around  the  15th  d  of 
incubation.  It  is  interesting  that  this  coincides  with  the beginning  of the period  in 
which the embryo is susceptible to the induction of autoimmunity and lymphomas. 
By 21 d of development, the chick once again developed resistance to the induction 
of autoimmunity and lymphomas and yet remained susceptible to the  induction  of 
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observations in mice. Attempts to induce transplantation  tolerance in mice at birth 
were successful in only 8% of the animals, whereas 23%  and 43% of the mice were 
tolerant when  antigen  was given at  days  18 and  15 of gestation, respectively (41). 
This is not surprising, as cytotoxic killer precursor cells can be detected in the spleens 
of 2-d-old mice (42, 43). It is interesting, however, that the development at immuno- 
competence in the newly hatched chick, although apparently preventing the estab- 
lishment of lymphocyte chimerism and GVH tolerance, nevertheless, does not prevent 
the successful establishment of RBC chimerism. This suggests that tolerance to RBC- 
associated MHC  antigens  (both B-G and class I  [B-F] antigens)  might be easier to 
establish and maintain than tolerance to lymphocyte-associated, class II (B-L) anti- 
gens.  Despite  this,  by  16 wk,  RBC  chimerism  was  apparently eliminated with  no 
evidence for the continuous development of alloantibody to donor RBC alloantigens. 
The mechanism whereby chimerism was eliminated in these birds might, therefore, 
involve cell-mediated immunity, perhaps  directed against  B-G antigens, which  are 
known to be expressed on erythroid progenitor cells (1). This might contrast with the 
mechanism of elimination of RBC chimerism in the chimeras established at day 17, 
where anti-RBC alloantibody is produced and leads eventually to autoimmunity and 
lymphoma. 
Summary 
Hematopoietic chimeras were produced at four different stages of ontogeny between 
two allogeneic strains of chickens. All chimeras produced by parabiosis at day 12 of 
embryogenesis and the majority (83%) of the ones produced at day 15 by intravenous 
injection of allogeneic stem cells remained healthy, chimeric, and specifically tolerant 
at both the humoral and cell-mediated level throughout a 10ng examination period. 
Chimeras generated at day 17 of embryogenesis demonstrated specific unresponsive- 
ness at the cell-mediated level but produced specific anti-donor alloantibodies directed 
against erythrocyte-associated major histocompatibility complex (MHC)  (B-G) anti- 
gens. 
These chimeras  and  a  minority  (17%)  of the  chimeras  generated  at  day  15  of 
embryogenesis developed servere antibody-mediated autoimmune hemolytic anemia 
after the 5th mo of age and succumbed to massive bursal lymphomas and metastases 
by the  10th mo of age. The immunological and pathological characteristics of these 
birds appear to reflect an autoimmune state rather than one of tolerance. Erythroid 
chimeras generated at day 21  of ontogenic development displayed normal levels of 
GVH reactivity. These birds were eventually able to eliminate the chimeric state and 
remained healthy until deliberately killed. These results show that there is a critical 
period in embryogenesis during which the induction of allogeneic erythrocytic chi- 
merism leads to the development, in adult life, of severe autoimmune anemia, B cell 
lymphomas, and death. 
B-G MHC antigens are erythroid differentiation antigens of the chicken. Polymor- 
phic determinants on B-G antigens appear to be important cross-reactive determinants 
(with environmental  bacteria),  against  which  a  high  background  immunity exists. 
Evidence is presented that the immune response to B-G antigens is responsible for the 
development of autoimmunity and  other pathological events that  follow and  that 334  TOLERANCE  AND  AUTOIMMUNITY  TO  ERYTHROID  ANTIGENS 
tolerance  to  class  I  MHC  antigens  (B-F  antigens)  shared  by  lymphocytes 
erythrocytes is maintained at the same time that B-G tolerance is broken. 
and 
Received  for publication 29 March 1982. 
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